Overview ADX10059 Migraine Prevention Study Status: Terminated Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Evaluation of ADX10059 to prevent migraine attacks Phase: Phase 2 Details Lead Sponsor: Addex Pharma S.A.